Analyzing Sonova (SONVY) & CONMED (CNMD)

Sonova (OTCMKTS: SONVY) and CONMED (NASDAQ:CNMD) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership.

Profitability

How to Become a New Pot Stock Millionaire

This table compares Sonova and CONMED’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Sonova N/A N/A N/A
CONMED 6.97% 8.96% 3.96%

Dividends

Sonova pays an annual dividend of $0.27 per share and has a dividend yield of 0.9%. CONMED pays an annual dividend of $0.80 per share and has a dividend yield of 1.3%. CONMED pays out 40.6% of its earnings in the form of a dividend.

Valuation and Earnings

This table compares Sonova and CONMED’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Sonova $2.43 billion 4.18 $354.51 million N/A N/A
CONMED $796.39 million 2.21 $55.48 million $1.97 31.93

Sonova has higher revenue and earnings than CONMED.

Insider & Institutional Ownership

0.2% of Sonova shares are owned by institutional investors. Comparatively, 99.6% of CONMED shares are owned by institutional investors. 2.6% of CONMED shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current recommendations for Sonova and CONMED, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sonova 0 0 0 0 N/A
CONMED 0 3 1 0 2.25

CONMED has a consensus price target of $55.00, indicating a potential downside of 12.57%. Given CONMED’s higher possible upside, analysts clearly believe CONMED is more favorable than Sonova.

Summary

CONMED beats Sonova on 8 of the 12 factors compared between the two stocks.

Sonova Company Profile

Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment. It offers hearing instruments, cochlear implants, wireless communication products, and rechargeable hearing aids, as well as professional audiological services. The company provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand name; and professional audiological services under the Connect Hearing brand name. Sonova Holding offers its products through a sales and distribution network, which comprise approximately 50 Sonova-owned wholesale companies and 100 independent distributors; and AudioNova retail network of approximately 3,300 locations in 12 markets. It operates in the Americas, Europe, the Middle East, Africa, and the Asia/Pacific. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.

CONMED Company Profile

CONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. The Company provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. The Company’s product lines consist of orthopedic surgery, general surgery and surgical visualization. As of December 31, 2016, the Company’s products are distributed domestically directly to over 6,000 hospitals, surgery centers and other healthcare institutions, as well as through medical specialty distributors. The Company’s orthopedic surgery product lines include sports medicine, powered surgical instruments, and sports biologics and tissue. These products are marketed under a range of brands, including Hall, CONMED Linvatec, Concept and Shutt.

Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

CommunityOne Bancorp  Earns News Impact Score of 0.19
CommunityOne Bancorp Earns News Impact Score of 0.19
Zcash Price Hits $267.03
Zcash Price Hits $267.03
Somewhat Positive Press Coverage Somewhat Unlikely to Affect New York REIT  Share Price
Somewhat Positive Press Coverage Somewhat Unlikely to Affect New York REIT Share Price
WPP  vs. Telaria  Head-To-Head Survey
WPP vs. Telaria Head-To-Head Survey
Brokerages Set Spero Therapeutics  Price Target at $27.67
Brokerages Set Spero Therapeutics Price Target at $27.67
Critical Contrast: XO Group  versus FTD Companies
Critical Contrast: XO Group versus FTD Companies


© 2006-2018 Ticker Report. Google+.